0001889938-26-000002.txt : 20261119
0001889938-26-000002.hdr.sgml : 20261119
20261119152400
ACCESSION NUMBER: 0001889938-26-000002
CONFORMED SUBMISSION TYPE: D/A
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering
FILED AS OF DATE: 20261119
DATE AS OF CHANGE: 20261119
EFFECTIVENESS DATE: 20261119
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Anuncia Medical, Inc.
CENTRAL INDEX KEY: 0001889938
ORGANIZATION NAME:
EIN: 824114865
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D/A
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-523914
FILM NUMBER: 261574394
BUSINESS ADDRESS:
STREET 1: 1355 N. SCOTTSDALE RD
STREET 2: SUITE 370
CITY: SCOTTSDALE
STATE: AZ
ZIP: 85257
BUSINESS PHONE: (513)-500-6736
MAIL ADDRESS:
STREET 1: 1355 N. SCOTTSDALE RD
STREET 2: SUITE 370
CITY: SCOTTSDALE
STATE: AZ
ZIP: 85257
FORMER COMPANY:
FORMER CONFORMED NAME: Anuncia, Inc.
DATE OF NAME CHANGE: 20211022
D/A
1
primary_doc.xml
X0708
D/A
LIVE
0001889938
Anuncia Medical, Inc.
10446 N. 74th St.
Suite 120
SCOTTSDALE
AZ
ARIZONA
85258
(513) 500-6736
DELAWARE
Anuncia, Inc.
Corporation
true
Elsa
Abruzzo
10446 N. 74th St.
Suite 120
Scottsdale
AZ
ARIZONA
85258
Executive Officer
Director
PJ
Anand
10446 N. 74th St.
Suite 120
Scottsdale
AZ
ARIZONA
85258
Director
Richard
Upton
10446 N. 74th St.
Suite 120
Scottsdale
AZ
ARIZONA
85258
Director
Edgar
D
Janotta
10446 N. 74th St.
Suite 120
Scottsdale
AZ
ARIZONA
85258
Director
Stephen
Oesterle
10446 N. 74th St.
Suite 120
Scottsdale
AZ
ARIZONA
85258
Director
Stanton
Rowe
10446 N. 74th St.
Suite 120
Scottsdale
AZ
ARIZONA
85258
Director
Ghassan
Kassab
10446 N. 74th St.
Suite 120
Scottsdale
AZ
ARIZONA
85258
Director
Darryl
Baker
10446 N. 74th St.
Suite 120
Scottsdale
AZ
ARIZONA
85258
Executive Officer
Biotechnology
Decline to Disclose
- 06b
true
0001889938-25-000002
2024-08-30
false
true
true
true
false
0
U.S. Boston Capital Corporation
5251
None
None
55 Old Bedford Road
Suite 202
Lincoln
MA
MASSACHUSETTS
01773
All States
false
18372472
16213083
2159389
Amounts include conversion of outstanding promissory notes. In addition, the
Company has offered 5-year warrants to purchase up to a maximum of 886,839
shares at $0.2819 per share.
false
102
0
66450
450000
true
false
Anuncia Medical, Inc.
/s/ Elsa Abruzzo
Elsa Abruzzo
President and CEO
2026-11-19